|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CD58-CAPZA1 (FusionGDB2 ID:14559) |
Fusion Gene Summary for CD58-CAPZA1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CD58-CAPZA1 | Fusion gene ID: 14559 | Hgene | Tgene | Gene symbol | CD58 | CAPZA1 | Gene ID | 965 | 829 |
| Gene name | CD58 molecule | capping actin protein of muscle Z-line subunit alpha 1 | |
| Synonyms | LFA-3|LFA3|ag3 | CAPPA1|CAPZ|CAZ1 | |
| Cytomap | 1p13.1 | 1p13.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | lymphocyte function-associated antigen 3CD58 antigen, (lymphocyte function-associated antigen 3)surface glycoprotein LFA-3 | F-actin-capping protein subunit alpha-1Cap ZcapZ alpha-1capping actin protein of muscle Z-line alpha subunit 1capping protein (actin filament) muscle Z-line, alpha 1 | |
| Modification date | 20200313 | 20200327 | |
| UniProtAcc | P19256 | P52907 | |
| Ensembl transtripts involved in fusion gene | ENST00000369487, ENST00000369489, ENST00000457047, | ENST00000476936, ENST00000263168, | |
| Fusion gene scores | * DoF score | 6 X 5 X 5=150 | 10 X 11 X 5=550 |
| # samples | 6 | 10 | |
| ** MAII score | log2(6/150*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/550*10)=-2.4594316186373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: CD58 [Title/Abstract] AND CAPZA1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CD58(117113524)-CAPZA1(113189831), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CD58 | GO:0034113 | heterotypic cell-cell adhesion | 15345303 |
| Hgene | CD58 | GO:0071346 | cellular response to interferon-gamma | 19109405 |
| Hgene | CD58 | GO:0071356 | cellular response to tumor necrosis factor | 19109405 |
| Fusion gene breakpoints across CD58 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across CAPZA1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | Non-Cancer | 2397N | CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + |
Top |
Fusion Gene ORF analysis for CD58-CAPZA1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-3UTR | ENST00000369487 | ENST00000476936 | CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + |
| 5CDS-3UTR | ENST00000369489 | ENST00000476936 | CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + |
| 5CDS-3UTR | ENST00000457047 | ENST00000476936 | CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + |
| In-frame | ENST00000369487 | ENST00000263168 | CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + |
| In-frame | ENST00000369489 | ENST00000263168 | CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + |
| In-frame | ENST00000457047 | ENST00000263168 | CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000369489 | CD58 | chr1 | 117113524 | - | ENST00000263168 | CAPZA1 | chr1 | 113189831 | + | 2446 | 137 | 11 | 958 | 315 |
| ENST00000457047 | CD58 | chr1 | 117113524 | - | ENST00000263168 | CAPZA1 | chr1 | 113189831 | + | 2433 | 124 | 10 | 945 | 311 |
| ENST00000369487 | CD58 | chr1 | 117113524 | - | ENST00000263168 | CAPZA1 | chr1 | 113189831 | + | 2446 | 137 | 11 | 958 | 315 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000369489 | ENST00000263168 | CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + | 0.000428863 | 0.99957114 |
| ENST00000457047 | ENST00000263168 | CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + | 0.000477954 | 0.9995221 |
| ENST00000369487 | ENST00000263168 | CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + | 0.000428863 | 0.99957114 |
Top |
Fusion Genomic Features for CD58-CAPZA1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + | 0.002727582 | 0.99727243 |
| CD58 | chr1 | 117113524 | - | CAPZA1 | chr1 | 113189831 | + | 0.002727582 | 0.99727243 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for CD58-CAPZA1 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:117113524/chr1:113189831) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CD58 | CAPZA1 |
| FUNCTION: Ligand of the T-lymphocyte CD2 glycoprotein. This interaction is important in mediating thymocyte interactions with thymic epithelial cells, antigen-independent and -dependent interactions of T-lymphocytes with target cells and antigen-presenting cells and the T-lymphocyte rosetting with erythrocytes. In addition, the LFA-3/CD2 interaction may prime response by both the CD2+ and LFA-3+ cells. | FUNCTION: F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. May play a role in the formation of epithelial cell junctions. {ECO:0000269|PubMed:22891260}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | CD58 | chr1:117113524 | chr1:113189831 | ENST00000369489 | - | 1 | 6 | 30_121 | 23 | 251.0 | Domain | Note=Ig-like |
| Hgene | CD58 | chr1:117113524 | chr1:113189831 | ENST00000457047 | - | 1 | 5 | 30_121 | 23 | 249.0 | Domain | Note=Ig-like |
| Hgene | CD58 | chr1:117113524 | chr1:113189831 | ENST00000369489 | - | 1 | 6 | 239_250 | 23 | 251.0 | Topological domain | Cytoplasmic |
| Hgene | CD58 | chr1:117113524 | chr1:113189831 | ENST00000369489 | - | 1 | 6 | 29_215 | 23 | 251.0 | Topological domain | Extracellular |
| Hgene | CD58 | chr1:117113524 | chr1:113189831 | ENST00000457047 | - | 1 | 5 | 239_250 | 23 | 249.0 | Topological domain | Cytoplasmic |
| Hgene | CD58 | chr1:117113524 | chr1:113189831 | ENST00000457047 | - | 1 | 5 | 29_215 | 23 | 249.0 | Topological domain | Extracellular |
| Hgene | CD58 | chr1:117113524 | chr1:113189831 | ENST00000369489 | - | 1 | 6 | 216_238 | 23 | 251.0 | Transmembrane | Helical |
| Hgene | CD58 | chr1:117113524 | chr1:113189831 | ENST00000457047 | - | 1 | 5 | 216_238 | 23 | 249.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for CD58-CAPZA1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >14559_14559_1_CD58-CAPZA1_CD58_chr1_117113524_ENST00000369487_CAPZA1_chr1_113189831_ENST00000263168_length(transcript)=2446nt_BP=137nt GTAGGCGGTGCTTGAACTTAGGGCTGCTTGTGGCTGGGCACTCGCGCAGAGGCCGGCCCGACGAGCCATGGTTGCTGGGAGCGACGCGGG GCGGGCCCTGGGGGTCCTCAGCGTGGTCTGCCTGCTGCACTGCTTTGGTACGCATAGCTGCTAAATTCATCACTCATGCACCCCCAGGGG AATTTAATGAAGTATTCAATGACGTTCGGCTACTACTTAATAATGACAATCTCCTCAGGGAAGGGGCAGCACATGCATTTGCCCAGTATA ACATGGATCAGTTCACGCCTGTGAAGATAGAAGGATATGAAGATCAGGTCTTAATTACAGAGCACGGTGACCTGGGTAATAGCAGATTTT TAGATCCAAGAAACAAAATTTCCTTTAAATTTGACCACTTACGGAAAGAAGCAAGTGACCCCCAGCCAGAAGAAGCAGATGGAGGTCTGA AGTCTTGGAGAGAATCCTGTGACAGTGCTTTAAGAGCCTATGTGAAAGACCATTATTCCAACGGCTTCTGTACTGTTTATGCTAAAACTA TCGATGGGCAACAGACTATTATTGCATGTATTGAAAGCCACCAGTTTCAGCCTAAAAACTTCTGGAATGGTCGTTGGAGATCAGAGTGGA AGTTCACCATCACACCACCTACAGCCCAGGTGGTTGGCGTGCTTAAGATTCAGGTTCACTATTATGAAGATGGCAATGTTCAGTTGGTTA GTCATAAAGATGTACAGGATTCACTAACTGTTTCGAATGAAGCCCAAACTGCCAAGGAGTTTATTAAAATCATAGAGAATGCAGAAAATG AGTATCAGACAGCAATTAGTGAAAACTATCAAACAATGTCAGATACCACATTCAAGGCCTTGCGCCGGCAGCTTCCAGTTACCCGCACCA AAATCGACTGGAACAAGATACTCAGCTACAAGATTGGCAAAGAAATGCAGAATGCTTAAAGGCTGAATGTAGGATTCTTCAGTATGTGGA AAGACAAGGATTCAACGTGTGGTCATATGATAAATAAGTGATTTATAAACAAGAGTGATATTTTGCTAGGGCTTTCAAAGTTAACCGGTT TTCTAGCCTCATGGAATACTGTTGAACCTATAGCGTTGTCTTGATTCTTTTGTGTTCTCTGCCTTGTAATTTTCTGTTACTGCTATATCT ACGTGTAAATCTTTTTTTCTTTTTTTTTTTTTTTTTTTGGTTAATTCTGCCACATTTAATGTTGGTGAGAGAGTGATCTATCCTAATGAC ATTTTACTGTTTAAAAAAGTTTCCTAGCCATGAAGCCCTGCTACTGATTTAGACAAGGTATTATGGTCATTACTTTGTACCCCTATCCTT CCAAGCACTTCTGGTACTTCAGTCGTTTTTACTGATCCACCAACACCTAAAGAGGCTATGCTACAGTCTCTAGCTAAATGGAAGACACAT TCATCCTTCTCCCTCTGACTGCTTTGATCATCATTTATTGCATCTCATAACTAATTTTCTAAAGTTTGGATTGGGACTTTTCAGGTCCTT TTTGGAGGGCAAAGGAAGTGCCAGCTTCTCTGGGGAACTTGTTTTTAAATCCAAAGACTTGAACCACATTCCCTGCACATGAACATGTTT GCTTTTATCCCTTCTCTCATTGTCTCCTTCCCATCTTAGTACCATTGTAGTTATAAACATCTGCATTTTTTAGAAGCATTTTACCCATTT ATTTTTTTAAACATTCAAGAACTGCTGACGTACTGTGGATGTAGAGTATAAAACTTGAAAAATGCAGATGTTGAAGGAATAATAGGTATC TTGTGCTTTAATACTTTATGGCAGGATTGTACTATAAGCAAATGAATTAAACAGCTATGTAAATCATAAAGAAAAACTAAAAATGAACCA AAGTGAAAGGATAACTTCCAGGCAGTATCTTTCTATTGTAACCTGTTATTTAAGGAAATACTAGTGATTTCTTCTAAATAGGATGTAAAA CTTCTTTCAAATTACTCTTCCTCAGTCCTGCCTGCCAAGAACTCAAGTGTAACTGTGATAAAATAACCTTTCCCAGGTATATTGGCAGGT ATGTGTGTAATCTCAGAATACACAGGTGACATAGATATGATATGACAACTGGTAATGGTGGATTCATTTACATTGTTTACACTTCTATGA CCAGGCCTTAAGGGAAGGTCAGTTTTTTAAAAAACCAAGTAGTGTCTTCCTACCTATCTCCAGATACATGTCAAAAAAAGAAAGGTGTTT GTGCTTCCGTTTTGTTTCTGCTCAGTAATATAGTCAAGCAAGTTTGTTCCAGGTGACCCATTGAGCTGTGTATGCATTTTTGTTTATTTC AATAAAATATATTTGTATTATTTGTCCTTCATACTATCCATCCATACCACACTATCTTCTGTATCAGGTAGTCTAATAGAAATATACCTG >14559_14559_1_CD58-CAPZA1_CD58_chr1_117113524_ENST00000369487_CAPZA1_chr1_113189831_ENST00000263168_length(amino acids)=315AA_BP=42 MNLGLLVAGHSRRGRPDEPWLLGATRGGPWGSSAWSACCTALVRIAAKFITHAPPGEFNEVFNDVRLLLNNDNLLREGAAHAFAQYNMDQ FTPVKIEGYEDQVLITEHGDLGNSRFLDPRNKISFKFDHLRKEASDPQPEEADGGLKSWRESCDSALRAYVKDHYSNGFCTVYAKTIDGQ QTIIACIESHQFQPKNFWNGRWRSEWKFTITPPTAQVVGVLKIQVHYYEDGNVQLVSHKDVQDSLTVSNEAQTAKEFIKIIENAENEYQT -------------------------------------------------------------- >14559_14559_2_CD58-CAPZA1_CD58_chr1_117113524_ENST00000369489_CAPZA1_chr1_113189831_ENST00000263168_length(transcript)=2446nt_BP=137nt GTAGGCGGTGCTTGAACTTAGGGCTGCTTGTGGCTGGGCACTCGCGCAGAGGCCGGCCCGACGAGCCATGGTTGCTGGGAGCGACGCGGG GCGGGCCCTGGGGGTCCTCAGCGTGGTCTGCCTGCTGCACTGCTTTGGTACGCATAGCTGCTAAATTCATCACTCATGCACCCCCAGGGG AATTTAATGAAGTATTCAATGACGTTCGGCTACTACTTAATAATGACAATCTCCTCAGGGAAGGGGCAGCACATGCATTTGCCCAGTATA ACATGGATCAGTTCACGCCTGTGAAGATAGAAGGATATGAAGATCAGGTCTTAATTACAGAGCACGGTGACCTGGGTAATAGCAGATTTT TAGATCCAAGAAACAAAATTTCCTTTAAATTTGACCACTTACGGAAAGAAGCAAGTGACCCCCAGCCAGAAGAAGCAGATGGAGGTCTGA AGTCTTGGAGAGAATCCTGTGACAGTGCTTTAAGAGCCTATGTGAAAGACCATTATTCCAACGGCTTCTGTACTGTTTATGCTAAAACTA TCGATGGGCAACAGACTATTATTGCATGTATTGAAAGCCACCAGTTTCAGCCTAAAAACTTCTGGAATGGTCGTTGGAGATCAGAGTGGA AGTTCACCATCACACCACCTACAGCCCAGGTGGTTGGCGTGCTTAAGATTCAGGTTCACTATTATGAAGATGGCAATGTTCAGTTGGTTA GTCATAAAGATGTACAGGATTCACTAACTGTTTCGAATGAAGCCCAAACTGCCAAGGAGTTTATTAAAATCATAGAGAATGCAGAAAATG AGTATCAGACAGCAATTAGTGAAAACTATCAAACAATGTCAGATACCACATTCAAGGCCTTGCGCCGGCAGCTTCCAGTTACCCGCACCA AAATCGACTGGAACAAGATACTCAGCTACAAGATTGGCAAAGAAATGCAGAATGCTTAAAGGCTGAATGTAGGATTCTTCAGTATGTGGA AAGACAAGGATTCAACGTGTGGTCATATGATAAATAAGTGATTTATAAACAAGAGTGATATTTTGCTAGGGCTTTCAAAGTTAACCGGTT TTCTAGCCTCATGGAATACTGTTGAACCTATAGCGTTGTCTTGATTCTTTTGTGTTCTCTGCCTTGTAATTTTCTGTTACTGCTATATCT ACGTGTAAATCTTTTTTTCTTTTTTTTTTTTTTTTTTTGGTTAATTCTGCCACATTTAATGTTGGTGAGAGAGTGATCTATCCTAATGAC ATTTTACTGTTTAAAAAAGTTTCCTAGCCATGAAGCCCTGCTACTGATTTAGACAAGGTATTATGGTCATTACTTTGTACCCCTATCCTT CCAAGCACTTCTGGTACTTCAGTCGTTTTTACTGATCCACCAACACCTAAAGAGGCTATGCTACAGTCTCTAGCTAAATGGAAGACACAT TCATCCTTCTCCCTCTGACTGCTTTGATCATCATTTATTGCATCTCATAACTAATTTTCTAAAGTTTGGATTGGGACTTTTCAGGTCCTT TTTGGAGGGCAAAGGAAGTGCCAGCTTCTCTGGGGAACTTGTTTTTAAATCCAAAGACTTGAACCACATTCCCTGCACATGAACATGTTT GCTTTTATCCCTTCTCTCATTGTCTCCTTCCCATCTTAGTACCATTGTAGTTATAAACATCTGCATTTTTTAGAAGCATTTTACCCATTT ATTTTTTTAAACATTCAAGAACTGCTGACGTACTGTGGATGTAGAGTATAAAACTTGAAAAATGCAGATGTTGAAGGAATAATAGGTATC TTGTGCTTTAATACTTTATGGCAGGATTGTACTATAAGCAAATGAATTAAACAGCTATGTAAATCATAAAGAAAAACTAAAAATGAACCA AAGTGAAAGGATAACTTCCAGGCAGTATCTTTCTATTGTAACCTGTTATTTAAGGAAATACTAGTGATTTCTTCTAAATAGGATGTAAAA CTTCTTTCAAATTACTCTTCCTCAGTCCTGCCTGCCAAGAACTCAAGTGTAACTGTGATAAAATAACCTTTCCCAGGTATATTGGCAGGT ATGTGTGTAATCTCAGAATACACAGGTGACATAGATATGATATGACAACTGGTAATGGTGGATTCATTTACATTGTTTACACTTCTATGA CCAGGCCTTAAGGGAAGGTCAGTTTTTTAAAAAACCAAGTAGTGTCTTCCTACCTATCTCCAGATACATGTCAAAAAAAGAAAGGTGTTT GTGCTTCCGTTTTGTTTCTGCTCAGTAATATAGTCAAGCAAGTTTGTTCCAGGTGACCCATTGAGCTGTGTATGCATTTTTGTTTATTTC AATAAAATATATTTGTATTATTTGTCCTTCATACTATCCATCCATACCACACTATCTTCTGTATCAGGTAGTCTAATAGAAATATACCTG >14559_14559_2_CD58-CAPZA1_CD58_chr1_117113524_ENST00000369489_CAPZA1_chr1_113189831_ENST00000263168_length(amino acids)=315AA_BP=42 MNLGLLVAGHSRRGRPDEPWLLGATRGGPWGSSAWSACCTALVRIAAKFITHAPPGEFNEVFNDVRLLLNNDNLLREGAAHAFAQYNMDQ FTPVKIEGYEDQVLITEHGDLGNSRFLDPRNKISFKFDHLRKEASDPQPEEADGGLKSWRESCDSALRAYVKDHYSNGFCTVYAKTIDGQ QTIIACIESHQFQPKNFWNGRWRSEWKFTITPPTAQVVGVLKIQVHYYEDGNVQLVSHKDVQDSLTVSNEAQTAKEFIKIIENAENEYQT -------------------------------------------------------------- >14559_14559_3_CD58-CAPZA1_CD58_chr1_117113524_ENST00000457047_CAPZA1_chr1_113189831_ENST00000263168_length(transcript)=2433nt_BP=124nt GAACTTAGGGCTGCTTGTGGCTGGGCACTCGCGCAGAGGCCGGCCCGACGAGCCATGGTTGCTGGGAGCGACGCGGGGCGGGCCCTGGGG GTCCTCAGCGTGGTCTGCCTGCTGCACTGCTTTGGTACGCATAGCTGCTAAATTCATCACTCATGCACCCCCAGGGGAATTTAATGAAGT ATTCAATGACGTTCGGCTACTACTTAATAATGACAATCTCCTCAGGGAAGGGGCAGCACATGCATTTGCCCAGTATAACATGGATCAGTT CACGCCTGTGAAGATAGAAGGATATGAAGATCAGGTCTTAATTACAGAGCACGGTGACCTGGGTAATAGCAGATTTTTAGATCCAAGAAA CAAAATTTCCTTTAAATTTGACCACTTACGGAAAGAAGCAAGTGACCCCCAGCCAGAAGAAGCAGATGGAGGTCTGAAGTCTTGGAGAGA ATCCTGTGACAGTGCTTTAAGAGCCTATGTGAAAGACCATTATTCCAACGGCTTCTGTACTGTTTATGCTAAAACTATCGATGGGCAACA GACTATTATTGCATGTATTGAAAGCCACCAGTTTCAGCCTAAAAACTTCTGGAATGGTCGTTGGAGATCAGAGTGGAAGTTCACCATCAC ACCACCTACAGCCCAGGTGGTTGGCGTGCTTAAGATTCAGGTTCACTATTATGAAGATGGCAATGTTCAGTTGGTTAGTCATAAAGATGT ACAGGATTCACTAACTGTTTCGAATGAAGCCCAAACTGCCAAGGAGTTTATTAAAATCATAGAGAATGCAGAAAATGAGTATCAGACAGC AATTAGTGAAAACTATCAAACAATGTCAGATACCACATTCAAGGCCTTGCGCCGGCAGCTTCCAGTTACCCGCACCAAAATCGACTGGAA CAAGATACTCAGCTACAAGATTGGCAAAGAAATGCAGAATGCTTAAAGGCTGAATGTAGGATTCTTCAGTATGTGGAAAGACAAGGATTC AACGTGTGGTCATATGATAAATAAGTGATTTATAAACAAGAGTGATATTTTGCTAGGGCTTTCAAAGTTAACCGGTTTTCTAGCCTCATG GAATACTGTTGAACCTATAGCGTTGTCTTGATTCTTTTGTGTTCTCTGCCTTGTAATTTTCTGTTACTGCTATATCTACGTGTAAATCTT TTTTTCTTTTTTTTTTTTTTTTTTTGGTTAATTCTGCCACATTTAATGTTGGTGAGAGAGTGATCTATCCTAATGACATTTTACTGTTTA AAAAAGTTTCCTAGCCATGAAGCCCTGCTACTGATTTAGACAAGGTATTATGGTCATTACTTTGTACCCCTATCCTTCCAAGCACTTCTG GTACTTCAGTCGTTTTTACTGATCCACCAACACCTAAAGAGGCTATGCTACAGTCTCTAGCTAAATGGAAGACACATTCATCCTTCTCCC TCTGACTGCTTTGATCATCATTTATTGCATCTCATAACTAATTTTCTAAAGTTTGGATTGGGACTTTTCAGGTCCTTTTTGGAGGGCAAA GGAAGTGCCAGCTTCTCTGGGGAACTTGTTTTTAAATCCAAAGACTTGAACCACATTCCCTGCACATGAACATGTTTGCTTTTATCCCTT CTCTCATTGTCTCCTTCCCATCTTAGTACCATTGTAGTTATAAACATCTGCATTTTTTAGAAGCATTTTACCCATTTATTTTTTTAAACA TTCAAGAACTGCTGACGTACTGTGGATGTAGAGTATAAAACTTGAAAAATGCAGATGTTGAAGGAATAATAGGTATCTTGTGCTTTAATA CTTTATGGCAGGATTGTACTATAAGCAAATGAATTAAACAGCTATGTAAATCATAAAGAAAAACTAAAAATGAACCAAAGTGAAAGGATA ACTTCCAGGCAGTATCTTTCTATTGTAACCTGTTATTTAAGGAAATACTAGTGATTTCTTCTAAATAGGATGTAAAACTTCTTTCAAATT ACTCTTCCTCAGTCCTGCCTGCCAAGAACTCAAGTGTAACTGTGATAAAATAACCTTTCCCAGGTATATTGGCAGGTATGTGTGTAATCT CAGAATACACAGGTGACATAGATATGATATGACAACTGGTAATGGTGGATTCATTTACATTGTTTACACTTCTATGACCAGGCCTTAAGG GAAGGTCAGTTTTTTAAAAAACCAAGTAGTGTCTTCCTACCTATCTCCAGATACATGTCAAAAAAAGAAAGGTGTTTGTGCTTCCGTTTT GTTTCTGCTCAGTAATATAGTCAAGCAAGTTTGTTCCAGGTGACCCATTGAGCTGTGTATGCATTTTTGTTTATTTCAATAAAATATATT TGTATTATTTGTCCTTCATACTATCCATCCATACCACACTATCTTCTGTATCAGGTAGTCTAATAGAAATATACCTGTTTTGTTCTAAAA >14559_14559_3_CD58-CAPZA1_CD58_chr1_117113524_ENST00000457047_CAPZA1_chr1_113189831_ENST00000263168_length(amino acids)=311AA_BP=38 MLVAGHSRRGRPDEPWLLGATRGGPWGSSAWSACCTALVRIAAKFITHAPPGEFNEVFNDVRLLLNNDNLLREGAAHAFAQYNMDQFTPV KIEGYEDQVLITEHGDLGNSRFLDPRNKISFKFDHLRKEASDPQPEEADGGLKSWRESCDSALRAYVKDHYSNGFCTVYAKTIDGQQTII ACIESHQFQPKNFWNGRWRSEWKFTITPPTAQVVGVLKIQVHYYEDGNVQLVSHKDVQDSLTVSNEAQTAKEFIKIIENAENEYQTAISE -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CD58-CAPZA1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CD58-CAPZA1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CD58-CAPZA1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies